208 related articles for article (PubMed ID: 16817200)
21. Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor.
Abouantoun TJ; MacDonald TJ
Mol Cancer Ther; 2009 May; 8(5):1137-47. PubMed ID: 19417143
[TBL] [Abstract][Full Text] [Related]
22. Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes.
Artemenko Y; Gagnon A; Sorisky A
J Cell Physiol; 2009 Jan; 218(1):228-36. PubMed ID: 18814181
[TBL] [Abstract][Full Text] [Related]
23. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia.
Dong LH; Wen JK; Miao SB; Jia Z; Hu HJ; Sun RH; Wu Y; Han M
Cell Res; 2010 Nov; 20(11):1252-62. PubMed ID: 20661261
[TBL] [Abstract][Full Text] [Related]
24. Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation.
Nykänen AI; Krebs R; Tikkanen JM; Raisky O; Sihvola R; Wood J; Koskinen PK; Lemström KB
Transplantation; 2005 Jan; 79(2):182-9. PubMed ID: 15665766
[TBL] [Abstract][Full Text] [Related]
25. Pro-apoptotic effects of imatinib on PDGF-stimulated pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension.
Nakamura K; Akagi S; Ogawa A; Kusano KF; Matsubara H; Miura D; Fuke S; Nishii N; Nagase S; Kohno K; Morita H; Oto T; Yamanaka R; Otsuka F; Miura A; Yutani C; Ohe T; Ito H
Int J Cardiol; 2012 Aug; 159(2):100-6. PubMed ID: 21376411
[TBL] [Abstract][Full Text] [Related]
26. Preadipocyte apoptosis is prevented by macrophage-conditioned medium in a PDGF-dependent manner.
Molgat AS; Gagnon A; Sorisky A
Am J Physiol Cell Physiol; 2009 Apr; 296(4):C757-65. PubMed ID: 19225164
[TBL] [Abstract][Full Text] [Related]
27. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.
Millette E; Rauch BH; Defawe O; Kenagy RD; Daum G; Clowes AW
Circ Res; 2005 Feb; 96(2):172-9. PubMed ID: 15625285
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effects of Brazilin on the vascular smooth muscle cell proliferation and migration induced by PDGF-BB.
Guo J; Li L; Wu YJ; Yan Y; Xu XN; Wang SB; Yuan TY; Fang LH; Du GH
Am J Chin Med; 2013; 41(6):1283-96. PubMed ID: 24228601
[TBL] [Abstract][Full Text] [Related]
29. Sodium butyrate inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells.
Ranganna K; Joshi T; Yatsu FM
Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2273-83. PubMed ID: 7489253
[TBL] [Abstract][Full Text] [Related]
30. Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression.
Beppu K; Jaboine J; Merchant MS; Mackall CL; Thiele CJ
J Natl Cancer Inst; 2004 Jan; 96(1):46-55. PubMed ID: 14709738
[TBL] [Abstract][Full Text] [Related]
31. Imatinib induces apoptosis by inhibiting PDGF- but not insulin-induced PI 3-kinase/Akt survival signaling in RGC-5 retinal ganglion cells.
Biswas SK; Zhao Y; Sandirasegarane L
Mol Vis; 2009 Aug; 15():1599-610. PubMed ID: 19693287
[TBL] [Abstract][Full Text] [Related]
32. Cudratricusxanthone A isolated from the root bark of Cudrania tricuspidata inhibits the proliferation of vascular smooth muscle cells through the suppression of PDGF-receptor beta tyrosine kinase.
Kim TJ; Han HJ; Hong SS; Hwang JH; Hwang BY; Yoo HS; Jin YR; Lee JJ; Yu JY; Lee KH; Kang BW; Yun YP
Biol Pharm Bull; 2007 Apr; 30(4):805-9. PubMed ID: 17409526
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G
Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571.
McGary EC; Weber K; Mills L; Doucet M; Lewis V; Lev DC; Fidler IJ; Bar-Eli M
Clin Cancer Res; 2002 Nov; 8(11):3584-91. PubMed ID: 12429650
[TBL] [Abstract][Full Text] [Related]
35. Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo.
Ballinger ML; Osman N; Hashimura K; de Haan JB; Jandeleit-Dahm K; Allen T; Tannock LR; Rutledge JC; Little PJ
J Cell Mol Med; 2010 Jun; 14(6B):1408-18. PubMed ID: 19754668
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.
Dahring TK; Lu GH; Hamby JM; Batley BL; Kraker AJ; Panek RL
J Pharmacol Exp Ther; 1997 Jun; 281(3):1446-56. PubMed ID: 9190882
[TBL] [Abstract][Full Text] [Related]
37. Clitocybin B inhibits rat aortic smooth muscle cell proliferation through suppressing PDGF-Rβ phosphorylation.
Yoo KD; Park ES; Lim Y; Kang SI; Yoo SH; Won HH; Lee HP; Kim YH; Yoo ID; Yoo HS; Hong JT; Yun YP
Vascul Pharmacol; 2012; 56(1-2):91-7. PubMed ID: 22166585
[TBL] [Abstract][Full Text] [Related]
38. Lycopene binds PDGF-BB and inhibits PDGF-BB-induced intracellular signaling transduction pathway in rat smooth muscle cells.
Lo HM; Hung CF; Tseng YL; Chen BH; Jian JS; Wu WB
Biochem Pharmacol; 2007 Jun; 74(1):54-63. PubMed ID: 17449016
[TBL] [Abstract][Full Text] [Related]
39. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
[TBL] [Abstract][Full Text] [Related]
40. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]